Maganin kamuwa da cutar Hp 

Bayani na 17:Matsakaicin ƙimar magani ga ka'idojin layin farko ga nau'ikan da ke da saurin kamuwa da cuta ya kamata ya zama aƙalla kashi 95% na marasa lafiya da aka warkar bisa ga nazarin saitin yarjejeniya (PP), kuma matsakaicin ƙimar maganin bincike na ganganci (ITT) ya kamata ya zama kashi 90% ko sama da haka. (Matakin shaida: babba; matakin da aka ba da shawarar: ƙarfi)

Bayani na 18:Amoxicillin da tetracycline ba su da ƙarfi kuma ba su da ƙarfi. Juriyar Metronidazole gabaɗaya ta fi yawa a ƙasashen ASEAN. Juriyar clarithromycin tana ƙaruwa a wurare da yawa kuma ta rage yawan kawar da maganin sau uku na yau da kullun. (Matsayin shaida: babba; matakin da aka ba da shawarar: N/A)

Bayani na 19:Idan ƙimar juriyar clarithromycin ta kai kashi 10% zuwa 15%, ana ɗaukarta a matsayin babban ƙarfin juriya, kuma an raba yankin zuwa yanki mai ƙarfi da kuma yanki mai ƙarancin juriya. (Matsayin Shaida: Matsakaici; Matsayin da Aka Ba da Shawara: Ba a yarda da shi ba)

Bayani na 20:Ga yawancin jiyya, kwas ɗin 14d shine mafi kyau kuma ya kamata a yi amfani da shi. Za a iya karɓar gajeriyar hanyar magani ne kawai idan an tabbatar da cewa ya cimma matsakaicin kashi 95% na ƙimar warkarwa ta hanyar PP ko kuma kashi 90% na ƙimar warkarwa ta hanyar nazarin ITT. (Matakin shaida: babba; matakin da aka ba da shawarar: ƙarfi)

Bayani na 21:Zaɓar hanyoyin magani na farko da aka ba da shawarar ya bambanta dangane da yanki, wurin da ake zaune, da kuma yanayin juriyar maganin rigakafi da marasa lafiya da aka sani ko ake tsammani. (Matakin shaida: babba; matakin da aka ba da shawarar: ƙarfi)

Bayani na 22:Tsarin magani na biyu ya kamata ya haɗa da maganin rigakafi waɗanda ba a taɓa amfani da su ba a da, kamar amoxicillin, tetracycline, ko maganin rigakafi waɗanda ba su da ƙarfin juriya. (Matsayin shaida: babba; matakin da aka ba da shawarar: ƙarfi)

Bayani na 23:Babban abin da ake nufi da gwajin kamuwa da cutar shan maganin rigakafi shi ne a yi jiyya bisa ga larura, wanda ake yi a halin yanzu bayan gazawar maganin layi na biyu. (Matakin shaida: babba; ƙimar da aka ba da shawarar: ƙarfi) 

Bayani na 24:Inda zai yiwu, ya kamata a yi maganin gyara bisa ga gwajin jijiyoyi. Idan gwajin jijiyoyi ba zai yiwu ba, bai kamata a haɗa magunguna masu juriya ga magunguna ba, kuma a yi amfani da magunguna masu ƙarancin juriya ga magunguna. (Matsayin shaida: babba; ƙimar da aka ba da shawarar: ƙarfi)

Bayani na 25:Hanya don ƙara yawan kawar da Hp ta hanyar ƙara tasirin hana ɓoyewar PPI tana buƙatar nau'in halittar CYP2C19 mai masaukin baki, ko dai ta hanyar ƙara yawan PPI na metabolism ko ta amfani da PPI wanda CYP2C19 ba shi da tasiri sosai. (Matsayin shaida: babba; ƙimar da aka ba da shawarar: ƙarfi)

Bayani na 26:Idan akwai juriya ga metronidazole, ƙara yawan maganin metronidazole zuwa 1500 mg/rana ko fiye da haka da kuma tsawaita lokacin maganin zuwa kwanaki 14 zai ƙara yawan maganin sau huɗu tare da maganin expectorant. (Matsayin shaida: babba; ƙimar da aka ba da shawarar: ƙarfi)

Bayani na 27:Ana iya amfani da probiotics a matsayin maganin kari don rage mummunan sakamako da inganta haƙuri. Amfani da probiotics da magani na yau da kullun na iya haifar da ƙaruwa mai dacewa a cikin ƙimar kawar da ƙwayoyin cuta. Duk da haka, waɗannan fa'idodin ba a nuna cewa suna da tasiri a farashi ba. (Matsayin shaida: babba; ƙimar da aka ba da shawarar: rauni)

Bayani na 28:Mafita gama gari ga marasa lafiya da ke da rashin lafiyar penicillin ita ce amfani da maganin sau huɗu tare da maganin expectorant. Sauran zaɓuɓɓuka sun dogara ne akan yanayin kamuwa da cutar a cikin gida. (Matsayin shaida: babba; ƙimar da aka ba da shawarar: ƙarfi)

Bayani na 29:Adadin sake kamuwa da cutar Hp da ƙasashen ASEAN suka bayar da rahotonsa a kowace shekara shine 0-6.4%. (Matsayin shaida: matsakaici) 

Bayani na 30:Ana iya gane matsalar rashin lafiyar da ke da alaƙa da Hp. A cikin marasa lafiya da ke da matsalar rashin lafiyar da ke da kamuwa da Hp, idan an rage alamun rashin lafiyar bayan an kawar da Hp cikin nasara, waɗannan alamun za a iya danganta su da kamuwa da Hp. (Matsayin shaida: babba; ƙimar da aka ba da shawarar: ƙarfi)

Mai bibiya

Bayani 31:31a:Ana ba da shawarar yin gwajin da ba shi da haɗari don tabbatar da ko an kawar da cutar Hp a cikin marasa lafiya da ke da ciwon duodenal.

                    31b:Yawanci, a makonni 8 zuwa 12, ana ba da shawarar yin gwajin gastroscopy ga marasa lafiya da ke fama da ciwon ciki don yin rikodin warkar da ciwon gaba ɗaya. Bugu da ƙari, idan ciwon bai warke ba, ana ba da shawarar yin gwajin biopsy na mucosa na ciki don kawar da cutar. (Matsayin shaida: babba; ƙimar da aka ba da shawarar: ƙarfi)

Bayani na 32:Da farko da kuma marasa lafiya da ke fama da cutar sankarar ciki ta MALT lymphoma mai kamuwa da cutar Hp dole ne su tabbatar ko an kawar da cutar Hp cikin nasara aƙalla makonni 4 bayan magani. Ana ba da shawarar a ci gaba da amfani da endoscopy. (Matsayin shaida: babba; ƙimar da aka ba da shawarar: ƙarfi)